Husam Younis
CIK: 0002107586
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNA
Atrium Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Younis Husam
Younis Husam (SEC CIK 0002107586) files insider reports with the SEC as Chief Scientific Officer of Atrium Therapeutics, Inc. (RNA).
Signal8 holds 3 ownership filings by Younis Husam (1 Form 3, 2 Form 4), filed between Feb 26, 2026 and Sep 22, 2026. Those filings report 2 transactions, from Apr 20, 2026 to Sep 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Younis Husam's filings is in SAN DIEGO, CA.
Recent filings by Younis Husam
Other insiders filing for Atrium Therapeutics, Inc. (RNA)
- Hughes Steven George, Chief Medical Officer
- Flanagan W. Michael, Director
- Boyce Sarah, Director
- Kenney Stephanie
- Gallagher Kathleen P.
- Winslow Brendan R., Chief Financial Officer